This Common Heart Attack Drug May Actually Be Worthless for Most People
A common treatment given after heart attacks may not be worthwhile for a large segment of the population. New trial data finds that most people who suffer a heart attack do not benefit from taking beta-blockers afterward. A large international team of researchers conducted the trial, which compared the outcomes of nearly 10,000 heart attack patients who were either given beta-blocker therapy or not. “This trial will reshape all international clinical guidelines.’ On average, people with prese